Urgent.News

What's breaking now, across thousands of outlets.

AI

Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer's

Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

We haven't written up this one. Economic Times Tech has the full story — the link below goes straight to it.

Read the original at economictimes.indiatimes.com →

More in AI

Oncology Needs Living Evidence, Not More AI Summaries | Opinion

AI could keep cancer evidence current, but clinical tools must be validated, traceable and governed by qualified experts.

  • Precision oncology increases treatment options but complicates evidence management.
  • Oncologists must consult multiple sources, leading to fragmented evidence infrastructure.
  • AI should create systems to continuously update and maintain evidence for treatment decisions.

More from Friday 23 October →